Betatrophin: A promising biomarker for metabolic syndrome and diabetes mellitus risk screening in teenagers
Article Sidebar
Main Article Content
https://orcid.org/0000-0002-3935-4848
Aulanni’am Aulanni’am
https://orcid.org/0000-0002-8446-6291
Dyah Kinasih Wuragil
https://orcid.org/0000-0003-0817-3865
Ahmad Taufiq
https://orcid.org/0000-0002-0155-6495
Sunaryono Sunaryono
https://orcid.org/0000-0001-5033-3549
Jerry Dwi Trijoyo Purnomo
https://orcid.org/0000-0001-5150-5066
Dyah Ika Krisnawati
https://orcid.org/0000-0003-1707-5191
Moch Sholeh
https://orcid.org/0009-0006-8061-3078
Abstract
Metabolic syndrome (MetS) and diabetes mellitus (DM) have become primary concerns worldwide, especially among the younger population. The Indonesian Boarding School model (IBS/Boarding School) is a large education system with a significant number of pupils (teenagers) and has the potential to become a center for metabolic disease, particularly among teenagers, due to their daily intake. This study aimed to provide a baseline screening for MetS and the risk of DM development in Boarding School teenagers. During this observational study, 90 healthy serological samples were obtained from senior and junior high school students. The circulating level of betatrophin was measured using a human betatrophin ELISA kit. Additionally, metabolic syndrome and DM screening data were analyzed using a rapid reverse-flow immunochromatography kit for 65 kDa glutamic acid decarboxylase (GAD65). Among the 90 healthy students, a high prevalence of GAD65 was observed, indicating a potential risk factor for metabolic diseases. Furthermore, higher serum betatrophin levels were observed in the samples. The circulating level of betatrophin was found to have a significant correlation with age, gender, body mass index (BMI), systolic blood pressure (SBP), fasting blood glucose (FBG), sleeping duration, and duration of stay at Boarding School (p < 0.05). Betatrophin emerged as a potential predictor of BMI, SBP, and FBG in students (p < 0.05). Both betatrophin and GAD65 have shown promise as future biomarkers, opening up a new avenue for assessing metabolic syndrome and the risk of DM. This underscores the importance of future programs in Boarding Schools focusing on MetS and DM prevention management, making the audience feel the significance of their work in addressing these pressing health issues.
Downloads
Article Details
Copyright (c) 2025 Hendra Susanto, Aulanni’am Aulanni’am, Dyah Kinasih Wuragil, Ahmad Taufiq, Sunaryono Sunaryono, Jerry Dwi Trijoyo Purnomo, Dyah Ika Krisnawati, Moch Sholeh
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Lee MK, Lee JH, Sohn SY, Ahn J, Hong OK, Kim MK, et al. Cumulative exposure to metabolic syndrome in a national population-based cohort of young adults and sex-specific risk for type 2 diabetes. Diabetol Metab Syndr. 2023;15(1):78. https://doi.org/10.1186/s13098-023-01030-z
Alfaqeeh M, Alfian SD, Abdulah R. Factors associated with diabetes mellitus among adults: Findings from the Indonesian family life survey-5. Enocr Metab Sci. 2024;14(74):100161. https://doi.org/10.1016/j.endmts.2024.100161
Fang Y, Liu W, Cai X, Zhu Y, Zhang M, Gong S, et al. Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM). Diabetol Metab Syndr. 2025;17(1):49. https://doi.org/10.1186/s13098-025-01602-1
Gong B, Yang W, Xing Y, Lai Y, Shan Z. Global, regional, and national burden of type 1 diabetes in adolescents and young adults. Pediatr Res. 2024;1–9. https://doi.org/10.1038/s41390-024-03107-5
Wagenknecht LE, Lawrence JM, Isom S, Jensen ET, Dabelea D, Liese AD, et al. Trends in incidence of youth-onset type 1 and type 2 diabetes, 2002–2018: Results from the US population-based SEARCH for diabetes in youth study. Lancet Diabetes Endocrinol. 2023;11(4):242–50. https://doi.org/10.1016/S2213-8587(23)00025-6
Schäfer M, Nadeau KJ, Reusch JEB. Cardiovascular disease in young people with type 1 diabetes: Search for cardiovascular biomarkers. J Diabetes Complications. 2020;34(10):107651. https://doi.org/10.1016/j.jdiacomp.2020.107651
Lin J, Cui K, Xu Y, Tang X, Shi Y, Lu X, et al. Inhibition of CD146 attenuates retinal neovascularization via vascular endothelial growth factor receptor 2 signalling pathway in proliferative diabetic retinopathy. Acta Ophthalmologica. 2022;100(4):e899–911. https://doi.org/10.1111/aos.15007
Denimal D, Monier S, Simoneau I, Duvillard L, Vergès B, Bouillet B. HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control. Cardiovasc Diabetol. 2022;21(1):154. https://doi.org/10.1186/s12933-022-01591-9
Holman N, Wild SH, Gregg EW, Valabhji J, Sattar N, Khunti K, et al. Comparison of mortality in people with type 1 and type 2 diabetes by age of diagnosis: an incident population-based study in England and Wales. Lancet Diabetes Encocrinol. 2022;10(2):95–7. https://doi.org/10.1016/S2213-8587(21)00293-X
Colom C, Rull A, Sanchez-Quesada JL, Pérez A. Cardiovascular disease in type 1 diabetes mellitus: epidemiology and management of cardiovascular risk. J Clin Med. 2021;10(8):1798. https://doi.org/10.3390/jcm10081798
Assa’Idi S. The growth of pesantren in Indonesia as the islamic venue and social class status of santri. EJER. 2021;21(93):425-440. https://doi.org/10.14689/ejer.2021.93.21
Nauli SNN, Bardosono S, Wiradnyani LA. Nutritional status indicator and its correlation with mental health score among adolescents in Islamic boarding schools. World Nutrition J. 2021;5(1):95–105. http://orcid.org/0000-0002-4349-8588
Alotaibi AD, Alosaimi FM, Alajlan AA, Bin Abdulrahman KA. The relationship between sleep quality, stress, and academic performance among medical students. J Family Community Med. 2020;27(1):23. https://doi.org/10.4103/jfcm.JFCM_132_19
Keikha F, Shahrokh Tehraninejad E, Rakhshkhorshid M, Afiat M, Hagholahi F, Ghasemi F. The association of the betatrophin level with metabolic and inflammatory parameters in infertile women with polycystic ovary syndrome: A case-control study. Int J Reprod Biomed. 2022;20(1):29–36. https://doi.org/10.18502/ijrm.v20i1.10406
Song Z, Guo K, Huang W, Xu H, Liu Y, Guan J, et al. Decreased serum betatrophin may correlate with the improvement of obstructive sleep apnea after Roux-en-Y Gastric Bypass surgery. Sci Rep. 2021;11(1):1808. https://doi.org/10.1038/s41598-021-81379-1
Tan X, Hu W, Yang S, Dai H, Xu S, Yang G, et al. Association of metabolic syndrome components with circulating levels of cytokine clusters in young women. Endocr Connect. 2020;10(1):66–75. https://doi.org/10.1530/ec-20-0569
Fu CP, Oczypok EE, Ali H, DeLany JP, Reeves VL, Chang RF, et al. Effect of physical activity in a weight loss program on circulating total ANGPTL8 concentrations in northern Americans with obesity: a prospective randomized controlled trial. Nutr Metab Cardiovasc Dis. 2022;32(7):1725–33. https://doi.org/10.1016/j.numecd.2022.04.006
Sonmez A, Dogru T, Ercin CN, Genc H, Celebi G, Gurel H, et al. Betatrophin levels are related to the early histological findings in nonalcoholic fatty liver disease. Metabolites. 2021;11(7):425. https://doi.org/10.3390/metabo11070425
Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep. 2015;4(1):5013. https://doi.org/10.1038/srep05013
Catalano-Iniesta L, Sánchez Robledo V, Iglesias-Osma MC, Galán Albiñana A, Carrero S, Blanco EJ, et al. Evidences for expression and location of ANGPTL8 in human adipose tissue. J Clin Med. 2020;9(2):512. https://doi.org/10.3390/jcm9020512
Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Cardiovasc Diabetol. 2016;15:13. https://doi.org/10.1186/s12933-015-0326-9
Susanto H, Liu TY, Chen CC, Purnomo JDT, Chen SF, Wang CH. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes. Oncotarget. 2016;7(27):42330-39. https://doi.org/10.18632/oncotarget.9815
Susanto H, Sugiharto, Taufiq A, Pranoto A, Purnomo JDT. Dynamic alteration of plasma levels of betatrophin in younger female onset obesity post acute moderate-intensity exercise training. Saudi J Biol Sci. 2023;30(2):103546. https://doi.org/10.1016/j.sjbs.2022.103546
Huang M, Chen W, Wang M, Huang Y, Liu H, Ming Y, et al. Advanced delivery strategies for immunotherapy in Type I diabetes mellitus. BioDrugs. 2023;37(3):331–52. https://doi.org/10.1007/s40259-023-00594-6
Rončáková M, Davani A, Mikušová V, Ságová I, Novodvorský P, Martinka E. Prevalence of positivity for diabetes-associated autoantibodies in individuals with type 2 diabetes and their further characterisation: cross-sectional study from Slovakia. Diabetes Ther. 2023;14(9):1537–48. https://doi.org/10.1007/s13300-023-01440-2
Jones AG, McDonald TJ, Shields BM, Hagopian W, Hattersley AT. Latent autoimmune diabetes of adults (LADA) is likely to represent a mixed population of autoimmune (Type 1) and nonautoimmune (Type 2) Diabetes. Diabetes Care. 2021;44(6):1243–51. https://doi.org/10.2337/dc20-2834
Long AE, George G, Williams CL. Persistence of islet autoantibodies after diagnosis in type 1 diabetes. Diabet Med. 2021;38(12):e14712. https://doi.org/10.1111/dme.14712
Koh HB, Heo GY, Kim KW, Ha J, Park JT, Han SH, et al. Trends in the association between body mass index and blood pressure among 19-year-old men in Korea from 2003 to 2017. Sci Rep. 2022;12(1):6767. https://doi.org/10.1038/s41598-022-10570-9
Nicolucci A, Maffeis C. The adolescent with obesity: what perspectives for treatment?. Ital J Pediatr. 2022;48:9. https://doi.org/10.1186/s13052-022-01205-w
Skogen IB, Høydal KL. Adolescents who are overweight or obese - the relevance of a social network to engaging in physical activity: a qualitative study. BMC Public Health. 2021;21(1):701. https://doi.org/10.1186/s12889-021-10727-7
Agbaje AO, Barker AR, Tuomainen TP. Effects of arterial stiffness and carotid intima-media thickness progression on the risk of overweight/obesity and elevated blood pressure/hypertension: a cross-lagged cohort study. Hypertension. 2022;79(1):159–69. https://doi.org/10.1161/HYPERTENSIONAHA.121.18449
Zhao W, Mo L, Pang Y. Hypertension in adolescents: The role of obesity and family history. J Clin Hypertens (Greenwich). 2021;23(12):2065–70. https://doi.org/10.1111/jch.14381
Fanelli E, Abate Daga F, Pappaccogli M, Eula E, Astarita A, Mingrone G, et al. A structured physical activity program in an adolescent population with overweight or obesity: a prospective interventional study. Appl Physiol Nutr Metab. 2022;47(3):253–60. https://doi.org/10.1139/apnm-2021-0092
Hassan MA, Zhou W, Ye M, He H, Gao Z. The effectiveness of physical activity interventions on blood pressure in children and adolescents: A systematic review and network meta-analysis. J Sport Health Sci. 2024;13(5):699–708. https://doi.org/10.1016/j.jshs.2024.01.004
Oranika US, Adeola OL, Egbuchua TO, Okobi OE, Alrowaili DG, Kajero A, et al. The Role of childhood obesity in early-onset type 2 diabetes mellitus: A scoping review. Cureus. 2023;15(10):e48037. https://doi.org/10.7759/cureus.48037
Sadler JR, Thapaliya G, Ranganath K, Gabay A, Chen L, Smith KR, et al. Paediatric obesity and metabolic syndrome associations with cognition and the brain in youth: Current evidence and future directions. Pediatr Obes. 2023;18(8):e13042. https://doi.org/10.1111/ijpo.13042
Toelsie JR, Morpurgo F, Krishnadath I, Bipat R. Obesity, overweight and hyperglycemia among primary school children in a low-middle income country with a multiethnic population. Obesity Pillars. 2023;5:100053. https://doi.org/10.1016/j.obpill.2022.100053
Brzeziński M, Metelska P, Myśliwiec M, Szlagatys-Sidorkiewicz A. Lipid disorders in children living with overweight and obesity-large cohort study from Poland. Lipids Health Dis. 2020;19:47. https://doi.org/10.1186/s12944-020-01218-6
Soliman H, Ibrahim A. Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes. Gaz Egypt Paediatr Assoc. 2021;69(1):21. https://doi.org/10.1186/s43054-021-00067-x
Tahrani AA, Morton J. Benefits of weight loss of 10% or more in patients with overweight or obesity: A review. Obesity. 2022;30(4):802–40. https://doi.org/10.1002/oby.23371
Anam MR, Akter S, Hossain F, Bonny SQ, Akter J, Zhang C, et al. Association of sleep duration and sleep quality with overweight/obesity among adolescents of Bangladesh: a multilevel analysis. BMC Public Health. 2022;22(1):374. https://doi.org/10.1186/s12889-022-12774-0
Seo SH, Shim YS. Association of sleep duration with obesity and cardiometabolic risk factors in children and adolescents: A population-based study. Sci Rep. 2019;9(1):9463. https://doi.org/10.1038/s41598-019-45951-0
Corrêa MM, Borges MA de S, Oliveira ERA de. Sleep duration and overweight: is there a relationship in adolescence? Rev Bras Epidemiol. 2021;24:e210031. https://doi.org/10.1590/1980-549720210031
Orta-Aleman D, Laraia BA. Sleep duration, overweight status, and the modifying role of food insecurity in a sample of 10- to 14-year-old Mexican early adolescents. Sleep Health. 2024;10(5):583–9. https://doi.org/10.1016/j.sleh.2024.06.005
Dahlawi M, Aldabbagh M, Alzubaidy BA, Dahlawi S, Alotaibi RN, Alsharif WK, et al. Association between smoking habits and body weight among general population in Saudi Arabia. Cureus. 2024;16(1):e51485. https://doi.org/10.7759/cureus.51485
Koyanagi A, Smith L, Oh H, Yang L, Jackson SE, Haro JM, et al. Secondhand smoking and obesity among nonsmoking adolescents aged 12–15 years from 38 low- and middle-income countries. Nicotine Tob Res. 2020;22(11):2014–21. https://doi.org/10.1093/ntr/ntaa053
Wang Q. Underweight, overweight, and tobacco use among adolescents aged 12–15 years: Evidence from 23 low-income and middle-income countries. Tob Induc Dis. 2021;19(May):1–12. https://doi.org/10.18332/tid/133932
Zheng J, Liu J, Hong BS, Ke W, Huang M, Li Y. Circulating betatrophin/ANGPTL8 levels correlate with body fat distribution in individuals with normal glucose tolerance but not those with glucose disorders. BMC Endocr Disord. 2020;20(1):51. https://doi.org/10.1186/s12902-020-0531-8
Hammad MM, Channanath AM, Abu-Farha M, Rahman A, Al Khairi I, Cherian P, et al. Adolescent obesity and ANGPTL8: correlations with high sensitivity C-reactive protein, leptin, and chemerin. Front Endocrinol. 2023;14:1314211. https://doi.org/10.3389/fendo.2023.1314211
Chen YQ, Zhen EY, Russell AM, Ehsani M, Siegel RW, Qian Y, et al. Decoding the role of angiopoietin-like protein 4/8 complex–mediated plasmin generation in the regulation of LPL activity. J Lipid Res. 2023;64(10):100441. https://doi.org/10.1016/j.bbrc.2013.01.129
Alenad A, Alenezi MM, Alokail MS, Wani K, Mohammed AK, Alnaami AM, et al. Association of ANGPTL8 (Betatrophin) gene variants with components of metabolic syndrome in arab adults. Sci Rep. 2020;10(1):6764. https://doi.org/10.1038/s41598-020-63850-7
Emara AM, El Bendary AS, Ahmed LM, Okda HI. Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy. BMC Nephrology. 2024;25(1):231. https://doi.org/10.1186/s12882-024-03663-2
Abu-Farha M, Abubaker J, Al-Khairi I, Cherian P, Noronha F, Kavalakatt S, et al. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome. Cardiovasc Diabetol. 2016;15:25. https://doi.org/10.1186/s12933-016-0346-0
Abu-Farha M, Madhu D, Hebbar P, Mohammad A, Channanath A, Kavalakatt S, et al. The proinflammatory role of ANGPTL8 R59W variant in modulating inflammation through NF-κB signaling pathway under TNFα stimulation. Cells. 2023;12(21):2563. https://doi.org/10.3390/cells12212563
Karaman ME, Arslan C, Gürsu MF. Effects of different exercise loads on serum betatrophin (ANGPTL-8/lipasin) and cartonectin (CTRP-3) levels in metabolic syndrome. Turk Biyokim Derg. 2022;47(1):71–8. https://doi.org/10.1515/tjb-2021-0120
Ideishi A, Suematsu Y, Tashiro K, Morita H, Kumagai-Koyanagi N, Kuwano T, et al. Changes in serum levels of angiopoietin-like protein-8 and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 after ezetimibe therapy in patients with dyslipidemia. Clinica Chimica Acta. 2020;510:675–80. https://doi.org/10.1016/j.cca.2020.08.030
Guo Q, Cao S, Wang X. Betatrophin and insulin resistance. Metabolites. 2022;12(10):925. https://doi.org/10.3390/metabo12100925
Lőrincz H, Csiha S, Ratku B, Somodi S, Sztanek F, Seres I, et al. Gender-dependent associations between serum betatrophin levels and lipoprotein subfractions in diabetic and nondiabetic obese patients. Int J Mol Sci. 2023;24(22):16504. https://doi.org/10.3390/ijms242216504
Zou H, Duan W, Zhang Z, Chen X, Lu P, Yu X. The circulating ANGPTL8 levels show differences among novel subgroups of adult patients with diabetes and are associated with mortality in the subsequent 5 years. Sci Rep. 2020;10:12859. https://doi.org/10.1038/s41598-020-69091-y
Tan X, Hu W, Yang S, Dai H, Xu S, Yang G, et al. Association of metabolic syndrome components with circulating levels of cytokine clusters in young women. Endocr Connect. 2020;10(1):66–75. https://doi.org/10.1530/EC-20-0569
Tavassoli H, Heidarianpour A. Associations between betatrophin with irisin and metabolic factors: effects of two exercise trainings in diabetic rats. Amer J Med Sci. 2021;362(5):496–505. https://doi.org/10.1016/j.amjms.2021.05.023
Gu Y, Jia X, Vartak T, Miao D, Dong F, Jerram ST, et al. Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes. Diabetologia. 2021;64(9):2052–60. https://doi.org/10.1007/s00125-021-05492-6
Li J, Lin S, Deng C, Xu T. Predictive value of GAD antibody for diabetes in normal Chinese adults: A retrospective cohort study in China. Diabetes Metab Syndr Obes. 2021;14:885–93. https://doi.org/10.2147/DMSO.S298068
Zong S, Vinke AM, Du P, Hoffmann C, Mané-Damas M, Molenaar PC, et al. Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1. Front Neurol. 2023;14:1111063. https://doi.org/10.3389/fneur.2023.1111063
Fan B, Lim CKP, Poon EWM, Lau ESH, Wu H, Yang A, et al. Differential associations of GAD antibodies (GADA) and C-peptide with insulin initiation, glycemic responses, and severe hypoglycemia in patients diagnosed with type 2 diabetes. Diabetes Care. 2023;46(6):1282–91. https://doi.org/10.2337/dc22-2301
Aulanni’am A, Wuragil DK, Susanto H, Herawati A, Nugroho YM, Laili Fajri WN, et al. The early detection of type 1 diabetes mellitus and latent autoimmune diabetes in adults (LADA) through rapid test reverse-flow immunochromatography for glutamic acid decarboxylase 65 kDa (GAD65). Heliyon. 2022;8(1):e08695. https://doi.org/10.1016/j.heliyon.2021.e08695
